Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV.

Paula Munderi Edwin Were Anchalee Avihingsanon Pascale A M Mbida Lerato Mohapi Samba B Moussa Marjolein Jansen Ceyhun Bicer Perry Mohammed Yvon van Delft

Published in: Southern African journal of HIV medicine (2019)

In adults with suppressed viral load on first-line NNRTI-based ART in LMICs, switching to an STR of TDF/FTC/RPV was non-inferior to TDF/FTC/EFV in maintaining high rates of viral suppression with a comparable tolerability profile.

Keyphrases

end stage renal disease
antiretroviral therapy
hiv infected
ejection fraction
newly diagnosed
chronic kidney disease
human immunodeficiency virus
sars cov
hepatitis c virus
peritoneal dialysis
hiv aids
randomized controlled trial
open label
hiv testing
clinical trial